Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1046/j.1365-2222.2003.01777.x http://scihub22266oqcxt.onion/10.1046/j.1365-2222.2003.01777.x 14519140!ä!14519140 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Clin+Exp+Allergy 2003 ; 33 (10): 1355-9 Nephropedia Template TP {{tp|p=14519140|t=2003. Oral magnesium and vitamin C supplements in asthma: a parallel group randomized placebo-controlled trial |pdf=|usr=}}{{14519140}} gab.com Text Oral magnesium and vitamin C supplements in asthma: a parallel group randomized placebo-controlled trial JO: Clin Exp Allergy http://www.kidney.de/pget.php?&tw=1&pmid=14519140 #FOAvip BACKGROUND: Epidemiological studies suggest that higher intakes of dietary vitamin C and magnesium may be associated with a reduced risk of asthma. OBJECTIVE: To determine whether vitamin C or magnesium supplements improve the clinical control of asthma in primary care patients. METHODS: A randomized, placebo-controlled, double-blind parallel group trial of 16 weeks supplementation with 1 g/day vitamin C, 450 mg/day magnesium chelate or matched placebo. Three hundred patients aged 18-60 years with physician-diagnosed asthma, controlled with at least one dose of an inhaled corticosteroid daily, were recruited from 24 primary care practices in Nottingham, UK. The main outcome measures were change in forced expiratory volume in 1 s, forced vital capacity, airway responsiveness to methacholine, mean morning and evening peak flow, symptom scores and bronchodilator use, both individually and as a combined summary statistic. RESULTS: There was no evidence of any beneficial effect of either supplement on any outcome measure of asthma control in the primary intention-to-treat analysis, or in an analysis restricted to participants who completed the study. CONCLUSIONS: Regular dietary supplementation with vitamin C or magnesium adds no clinical benefit to current standard therapy of asthma in primary care patients. Twit Text FOAVip Oral magnesium and vitamin C supplements in asthma: a parallel group randomized placebo-controlled trial ????Clin Exp Allergy http://www.kidney.de/pget.php?&tw=1&pmid=14519140 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=14519140 #FOAvip English Wikipedia <ref>{{Cite pmid|14519140}}</ref> Oral magnesium and vitamin C supplements in asthma: a parallel group randomized placebo-controlled trial #MMPMID14519140 Fogarty A; Lewis SA; Scrivener SL; Antoniak M; Pacey S; Pringle M; Britton J Clin Exp Allergy 2003[Oct]; 33 (10): 1355-9 PMID14519140show ga BACKGROUND: Epidemiological studies suggest that higher intakes of dietary vitamin C and magnesium may be associated with a reduced risk of asthma. OBJECTIVE: To determine whether vitamin C or magnesium supplements improve the clinical control of asthma in primary care patients. METHODS: A randomized, placebo-controlled, double-blind parallel group trial of 16 weeks supplementation with 1 g/day vitamin C, 450 mg/day magnesium chelate or matched placebo. Three hundred patients aged 18-60 years with physician-diagnosed asthma, controlled with at least one dose of an inhaled corticosteroid daily, were recruited from 24 primary care practices in Nottingham, UK. The main outcome measures were change in forced expiratory volume in 1 s, forced vital capacity, airway responsiveness to methacholine, mean morning and evening peak flow, symptom scores and bronchodilator use, both individually and as a combined summary statistic. RESULTS: There was no evidence of any beneficial effect of either supplement on any outcome measure of asthma control in the primary intention-to-treat analysis, or in an analysis restricted to participants who completed the study. CONCLUSIONS: Regular dietary supplementation with vitamin C or magnesium adds no clinical benefit to current standard therapy of asthma in primary care patients. |Adolescent[MESH] |Adult[MESH] |Ascorbic Acid/*therapeutic use[MESH] |Asthma/*drug therapy/physiopathology[MESH] |Double-Blind Method[MESH] |Female[MESH] |Humans[MESH] |Magnesium/*therapeutic use[MESH] |Male[MESH] |Middle Aged[MESH] |Primary Health Care/methods[MESH] |Respiratory Mechanics/drug effects[MESH] |Treatment Outcome[MESH]Oral magnesium and vitamin C supplements in asthma: a parallel group r(epmc).pdf DeepDyve Pubget Overpricing